Design, synthesis, and biological assessment of a novel 1H-benzopyrazole derivative as an antimicrobial QSI and dual anticancer agent targeting A549 and MCF7 cell lines

Copyright & License

Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

BibTeX

@article{176151,
        author = {Sunil Gorakh Gadakh},
        title = {Design, synthesis, and biological assessment of a novel 1H-benzopyrazole derivative as an antimicrobial QSI and dual anticancer agent targeting A549 and MCF7 cell lines},
        journal = {International Journal of Innovative Research in Technology},
        year = {2025},
        volume = {11},
        number = {11},
        pages = {7025-7040},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=176151},
        abstract = {},
        keywords = {1H-Benzopyrazole derivatives, Antitumor activity, Lung cancer, Breast cancer, ADME study, Molecular Docking},
        month = {April},
        }

Cite This Article

Gadakh, S. G. (2025). Design, synthesis, and biological assessment of a novel 1H-benzopyrazole derivative as an antimicrobial QSI and dual anticancer agent targeting A549 and MCF7 cell lines. International Journal of Innovative Research in Technology (IJIRT), 11(11), 7025–7040.

Related Articles